Study

EORTC-1944-QLG-STBSG

Long-term survivorship challenges of advanced/metastatic GIST patients responding to Imatinib treatment: An observational study

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 24-Mar-2021

Data management at EORTC

None

Design

QoL Non Module Study Development
Not randomized / N.A.

Treatment

None

Study Staff

  • Olga Husson (Study Coordinator), The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
  • Winette van der Graaf (Study Co-Coordinator), The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
  • Corneel Coens (Statistician), EORTC Headquarters, Brussels
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Francesca Martinelli (QoL Specialist), EORTC Headquarters, Brussels
  • Madeline Pe (QoL Specialist), EORTC Headquarters, Brussels

Type of cancer

  • Soft Tissue and Bone Sarcoma

Participating groups

  • EORTC Quality of Life Group
  • EORTC Soft Tissue and Bone Sarcoma Group